New EDCTP Executive Director from January 201616 July 2015

Dr. Michael Makanga will replace Professor Charles Mgone as Eecutive Director of The European & Developing Countries' Clinical Trials Partnership (EDCTP) in January 2016.

Dr. Makanga comes from a position as Head of EDCTP Africa Office in Cape Town, which he has held since 2008.

Read more

Advanced Vaccinology Course, deadline 19 October 201515 July 2015

The Institute of Tropical Medicine and International Health in Berlin is offering a two week Advanced Vaccinology Course at Campus Virchow Klinikum CVK Charité, Berlin, 11-22 January 2016.

Acess flyer for more information and application form

EVI mentioned in BMBF G7 news letter15 July 2015

A placental malaria vaccine R&D project from EVI (PRIMALVAC), funded by the Federal Ministry of Education and Research (BMBF), Germany is the subject of an article in the latest BMBF Health Research news letter.  The article provides some background information about placental malaria, and summarises the approach followed in PRIMALVAC to develop a vaccine for this particular form of malaria.  See page 10 “Malaria in der Schwangerschaft: Gefahr für Mutter und Kind".

EDUFLUVAC Workshop on immunoassay standardisation for universal flu vaccines22 June 2015

The first EDUFLUVAC workshop on immunoassay standardisation for universal flu vaccines took place on 18-19 June 2015 at the National Institute for Biological Standards and Control (NIBSC), UK.  This workshop was co-organised and co-sponsored by the National Institute of Health (NIH) / National Institute of Allergy and Infectious Diseases (NIAID), USA.

BELLEROPHON Call for process development and GMP manufacture of a vaccine candidate17 June 2015

BELLEROPHON would like to make a call for the process development and production in E. coli according to Good Manufacturing Practice (GMP) of a protein vaccine candidate to be used in toxicological and phase I studies.  The subcontracting is expected in Q4 2015.

MVVC/MVVC 2 meeting, Oxford 4 - 5 March 201517 June 2015

The annual meeting of MVVC / MVVC 2 held in Oxford in March is mentioned in the EDCTP May news letter (page 6).  Field trials of a new combination malaria vaccine, which are an integral part of the MVVC2 project, are funded by among others EDCTP.

EVI Rendez-Vous 201513 June 2015

Want to learn more about what EVI is doing, then join us for the 2015 Rendez-Vous on 9 December.

It is an increasing popular event, bringing together people from all corners of the scientific community, the European Commission and other like funders.

JAIVAC phase I clinical trial results published02 June 2015

The results of JAIVAC phase I clinical trial of a recombinant blood stage vaccine candidate for plasmodium falciparum malaria based on MSP1 and EBA175 were published in PLOS one in April 2015.
This project was supported financially by the Department of Biotechnology and Irish Aid.

EVI has currently two exciting career opportunities26 May 2015

Vaccine Management Assistant - new deadline 5 June 2015 17:00 CET.  Download PDF-version

An eighteen month junior position for a motivated individual for a phase I vaccine clinical trial.

Project Manager - deadline 15 June 2015 17:00 CET.  Download PDF-version

A three year junior position to work with international partners.

EVI would like to thank all those who applied for these positions, and for their interest in EVI.

MVVC: Publication of promising results from a recent vaccine clinical trial in Kenya10 May 2015

Results of a phase IIb clinical trial conducted in Kenya under the MVVC project were published 7 May 2015 in Science Translational Medicine.
Press release here